Johnson Financial Group Inc (Wisconsin)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.23M Sell
114,948
-23,366
-17% -$622K 0.12% 94
2025
Q4
$3.44M Buy
138,314
+20,169
+17% +$509K 0.13% 84
2025
Q3
$3.01M Sell
118,145
-3,352
-3% -$82.7K 0.11% 96
2025
Q2
$2.95M Buy
121,497
+35,003
+40% +$816K 0.13% 87
2025
Q1
$2.19M Buy
86,494
+28,063
+48% +$734K 0.11% 102
2024
Q4
$1.57M Sell
58,431
-31,627
-35% -$858K 0.07% 125
2024
Q3
$2.61M Sell
90,058
-1,595
-2% -$46.5K 0.12% 95
2024
Q2
$2.56M Sell
91,653
-20,792
-18% -$572K 0.12% 96
2024
Q1
$3.12M Buy
112,445
+33,074
+42% +$918K 0.17% 55
2023
Q4
$2.29M Sell
79,371
-61,027
-43% -$1.84M 0.13% 67
2023
Q3
$4.66M Buy
140,398
+9,404
+7% +$333K 0.32% 33
2023
Q2
$4.8M Buy
130,994
+2,326
+2% +$90.5K 0.33% 39
2023
Q1
$5.25M Buy
128,668
+21,518
+20% +$929K 0.37% 35
2022
Q4
$5.49M Buy
107,150
+1,024
+1% +$49.1K 0.44% 33
2022
Q3
$4.93M Sell
106,126
-20,228
-16% -$983K 0.45% 33
2022
Q2
$6.63M Sell
126,354
-1,806
-1% -$92K 0.47% 32
2022
Q1
$6.63M Sell
128,160
-7,038
-5% -$365K 0.47% 27
2021
Q4
$7.98M Sell
135,198
-3,638
-3% -$180K 0.51% 26
2021
Q3
$5.97M Sell
138,836
-9,772
-7% -$433K 0.41% 30
2021
Q2
$5.82M Buy
148,608
+8,859
+6% +$345K 0.38% 30
2021
Q1
$5.06M Buy
139,749
+28,344
+25% +$1.01M 0.34% 31
2020
Q4
$4.1M Sell
111,405
-11,277
-9% -$414K 0.35% 34
2020
Q3
$4.27M Buy
122,682
+32,386
+36% +$1.14M 0.44% 31
2020
Q2
$2.8M Sell
90,296
-45,141
-33% -$1.53M 0.3% 46
2020
Q1
$4.19M Sell
135,437
-1,216
-0.9% -$41.4K 0.5% 30
2019
Q4
$5.08M Sell
136,653
-42,694
-24% -$1.52M 0.46% 32
2019
Q3
$6.11M Sell
179,347
-6,212
-3% -$226K 0.56% 34
2019
Q2
$7.63M Buy
185,559
+14,199
+8% +$564K 0.68% 25
2019
Q1
$6.91M Buy
171,360
+4,945
+3% +$198K 0.61% 30
2018
Q4
$6.89M Sell
166,415
-18,272
-10% -$759K 0.71% 26
2018
Q3
$7.72M Buy
184,687
+32,153
+21% +$1.24M 0.79% 19
2018
Q2
$5.25M Buy
152,534
+2,198
+1% +$75.1K 0.58% 29
2018
Q1
$5.06M Buy
150,336
+6,890
+5% +$237K 0.61% 31
2017
Q4
$4.93M Buy
143,446
+1,655
+1% +$56.4K 0.6% 31
2017
Q3
$4.8M Buy
141,791
+5,992
+4% +$193K 0.63% 31
2017
Q2
$4.33M Sell
135,799
-53,370
-28% -$1.68M 0.62% 33
2017
Q1
$6.14M Sell
189,169
-16,436
-8% -$518K 0.77% 28
2016
Q4
$6.33M Sell
205,605
-12,044
-6% -$368K 0.87% 24
2016
Q3
$6.99M Buy
217,649
+565
+0.3% +$18.9K 0.93% 20
2016
Q2
$7.25M Buy
217,084
+7,978
+4% +$255K 1% 18
2016
Q1
$5.88M Buy
209,106
+3,845
+2% +$110K 1.18% 14
2015
Q4
$6.29M Buy
205,261
+12,806
+7% +$403K 1.31% 13
2015
Q3
$5.74M Buy
192,455
+18,852
+11% +$604K 1.26% 13
2015
Q2
$5.52M Buy
173,603
+1,104
+0.6% +$36K 1.14% 13
2015
Q1
$5.69M Sell
172,499
-3,481
-2% -$111K 1.22% 11
2014
Q4
$5.2M Sell
175,980
-693
-0.4% -$19.9K 1.21% 9
2014
Q3
$4.96M Buy
176,673
+970
+0.6% +$27.2K 1.29% 10
2014
Q2
$4.95M Buy
175,703
+7,148
+4% +$204K 1.3% 9
2014
Q1
$5.14M Buy
168,555
+49,556
+42% +$1.48M 1.5% 5
2013
Q4
$3.46M Buy
118,999
+4,249
+4% +$124K 1% 15
2013
Q3
$3.13M Buy
114,750
+7,073
+7% +$192K 0.95% 15
2013
Q2
$2.86M Buy
+107,677
New +$2.98M 0.8% 20

Other funds holding PFE

Johnson Financial Group Inc (Wisconsin)'s PFE Position: Q1 2026 in Review

Johnson Financial Group Inc (Wisconsin) reduced its Pfizer (PFE) stake by 17% in Q1 2026, selling an estimated $622K and leaving 114,948 shares worth $3.23M. The position accounts for 0.12% of the portfolio, ranked #94.

Johnson Financial Group Inc (Wisconsin) first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.98M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Johnson Financial Group Inc (Wisconsin) held 114,948 shares of Pfizer worth $3.23M as of Q1 2026.
  • Johnson Financial Group Inc (Wisconsin) sold 23,366 Pfizer shares in Q1 2026, an estimated $622K.
  • Pfizer made up 0.12% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q1 2026, its #94 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Johnson Financial Group Inc (Wisconsin)'s Pfizer position peaked at $7.98M in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2026, filed 7 May 2026.